Crisis in French Public Psychiatry: Doctor Shortages, Unequal Care, and the Persisting Use of Restraint
France's public psychiatric system faces a critical shortage of doctors (20% vacancy rate), unequal access to care, and ineffective oversight of involuntary hospitalizations (75,000 annually), leading to the continued use of mechanical restraint despite its lack of therapeutic value.
Crisis in French Public Psychiatry: Doctor Shortages, Unequal Care, and the Persisting Use of Restraint
France's public psychiatric system faces a critical shortage of doctors (20% vacancy rate), unequal access to care, and ineffective oversight of involuntary hospitalizations (75,000 annually), leading to the continued use of mechanical restraint despite its lack of therapeutic value.
Progress
60% Bias Score
J&J acquires Intra-Cellular Therapies for $14.6 Billion
Johnson & Johnson is acquiring Intra-Cellular Therapies for $14.6 billion, gaining control of Caplyta, a drug for schizophrenia and bipolar depression, with projected sales exceeding $1 billion in 2024 and $2.5 billion by 2028; the deal is expected to close later this year.
J&J acquires Intra-Cellular Therapies for $14.6 Billion
Johnson & Johnson is acquiring Intra-Cellular Therapies for $14.6 billion, gaining control of Caplyta, a drug for schizophrenia and bipolar depression, with projected sales exceeding $1 billion in 2024 and $2.5 billion by 2028; the deal is expected to close later this year.
Progress
36% Bias Score
UK COVID Inquiry to Investigate Social Media's Role in Vaccine Misinformation
The UK COVID-19 Inquiry's Module 4 will investigate the impact of social media misinformation and disinformation on vaccine hesitancy, aiming to improve future vaccination campaigns and public health messaging, with potential recommendations for social media regulation.
UK COVID Inquiry to Investigate Social Media's Role in Vaccine Misinformation
The UK COVID-19 Inquiry's Module 4 will investigate the impact of social media misinformation and disinformation on vaccine hesitancy, aiming to improve future vaccination campaigns and public health messaging, with potential recommendations for social media regulation.
Progress
40% Bias Score
Dementia Risk in US to Double by 2060: Study
New research shows 42% of Americans over 55 will develop dementia, with annual diagnoses projected to double by 2060 due to the aging population and racial disparities, highlighting the urgent need for preventative policies.
Dementia Risk in US to Double by 2060: Study
New research shows 42% of Americans over 55 will develop dementia, with annual diagnoses projected to double by 2060 due to the aging population and racial disparities, highlighting the urgent need for preventative policies.
Progress
24% Bias Score
Glasgow Opens First Safer Drug Consumption Room to Combat Drug Deaths
Glasgow's first safer drug consumption facility, The Thistle, opened on Monday, offering supervised drug use and support services to combat Scotland's drug-related deaths crisis, which saw 1,172 deaths in 2023, a 12% increase from the previous year.
Glasgow Opens First Safer Drug Consumption Room to Combat Drug Deaths
Glasgow's first safer drug consumption facility, The Thistle, opened on Monday, offering supervised drug use and support services to combat Scotland's drug-related deaths crisis, which saw 1,172 deaths in 2023, a 12% increase from the previous year.
Progress
44% Bias Score
Rising Matricide in Australia Highlights Need for Support Services
In Australia, matricide, the killing of a mother by her child, is increasingly common; in 2022-23, sixteen of eighty-four domestic homicide victims were parents of their killers. Cases highlight mental illness, substance abuse, and financial motives, underscoring the need for increased support servi...
Rising Matricide in Australia Highlights Need for Support Services
In Australia, matricide, the killing of a mother by her child, is increasingly common; in 2022-23, sixteen of eighty-four domestic homicide victims were parents of their killers. Cases highlight mental illness, substance abuse, and financial motives, underscoring the need for increased support servi...
Progress
52% Bias Score
NHS Weight-Loss Jab: High Cost Limits Access for Millions
Ray, 62, lost over two stone in five months using Wegovy via the NHS, but limited funding means only a tiny percentage of the 3.4 million eligible patients in England can access such treatments; the annual cost per patient is around £3,000.
NHS Weight-Loss Jab: High Cost Limits Access for Millions
Ray, 62, lost over two stone in five months using Wegovy via the NHS, but limited funding means only a tiny percentage of the 3.4 million eligible patients in England can access such treatments; the annual cost per patient is around £3,000.
Progress
52% Bias Score
Misinformation, Public Trust, and the Biden Administration's Pandemic Response
HHS Secretary Xavier Becerra cites online misinformation as a key factor in eroding public trust in health officials, while Meta CEO Mark Zuckerberg alleges the Biden administration pressured his company to censor vaccine-related content, highlighting a conflict between public health measures and fr...
Misinformation, Public Trust, and the Biden Administration's Pandemic Response
HHS Secretary Xavier Becerra cites online misinformation as a key factor in eroding public trust in health officials, while Meta CEO Mark Zuckerberg alleges the Biden administration pressured his company to censor vaccine-related content, highlighting a conflict between public health measures and fr...
Progress
44% Bias Score
Self-Destructing Tuberculosis Vaccine Shows Promise in Monkey Trials
American researchers created a self-destructing tuberculosis vaccine with a genetic 'kill switch' activated by an antibiotic; successful monkey trials showed enhanced efficacy and safety compared to the standard BCG vaccine, potentially enabling intravenous administration and broader protection.
Self-Destructing Tuberculosis Vaccine Shows Promise in Monkey Trials
American researchers created a self-destructing tuberculosis vaccine with a genetic 'kill switch' activated by an antibiotic; successful monkey trials showed enhanced efficacy and safety compared to the standard BCG vaccine, potentially enabling intravenous administration and broader protection.
Progress
44% Bias Score
Los Angeles Wildfires: Devastating Health Consequences for Survivors
The Los Angeles wildfires caused devastating losses, and survivors now face significant health risks from inhaling wildfire smoke containing PM2.5, including immediate respiratory issues, and long-term effects such as increased risk of heart and lung disease and mental health issues.
Los Angeles Wildfires: Devastating Health Consequences for Survivors
The Los Angeles wildfires caused devastating losses, and survivors now face significant health risks from inhaling wildfire smoke containing PM2.5, including immediate respiratory issues, and long-term effects such as increased risk of heart and lung disease and mental health issues.
Progress
24% Bias Score
Ethical Breach Allegations in Cannabis Cancer Research Project
An investigation is underway into a University of Newcastle and Ecofibre research project using cannabis to treat cancer, amid allegations of inadequate ethical approvals for human tissue use and potentially improper tests on a dying woman. The university's investigation focuses on ethical approval ...
Ethical Breach Allegations in Cannabis Cancer Research Project
An investigation is underway into a University of Newcastle and Ecofibre research project using cannabis to treat cancer, amid allegations of inadequate ethical approvals for human tissue use and potentially improper tests on a dying woman. The university's investigation focuses on ethical approval ...
Progress
64% Bias Score
AI Startup Collate Secures \$30 Million, Aims to Automate Life Sciences Documentation
Surbhi Sarna, after selling her previous startup nVision Medical for \$275 million, launched Collate, an AI-powered life sciences documentation automation startup, securing \$30 million in seed funding and a valuation exceeding \$100 million.
AI Startup Collate Secures \$30 Million, Aims to Automate Life Sciences Documentation
Surbhi Sarna, after selling her previous startup nVision Medical for \$275 million, launched Collate, an AI-powered life sciences documentation automation startup, securing \$30 million in seed funding and a valuation exceeding \$100 million.
Progress
48% Bias Score